Results 61 to 70 of about 8,668 (131)

High burden of CMV infections after simultaneous pancreas-kidney transplantation—a nationwide cohort study

Frontiers in Transplantation
Cytomegalovirus (CMV) infections remain a common problem after solid-organ transplantation. We characterized the burden of CMV infections, and adverse events of CMV prophylaxis after simultaneous pancreas-kidney transplantation (SPK). We included all SPK
Kaisa Ahopelto, Juulia Grasberger, Fernanda Ortiz, Agneta Ekstrand, Arno Nordin, Marko Lempinen, Ilkka Helanterä   +6 more
doaj   +1 more source

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence

Indian Journal of Respiratory Care, 2019
Cytomegalovirus (CMV) is the most common congenital viral infection in neonates. Postnatal infection regarding infants rarely has significant clinical consequences. However, preterm may be at higher risk of developing symptomatic postnatal CMV disease. A
Anumodan Gupta, Aditi Saini, Anukul Gowda, Sandeep Kadam   +3 more
doaj   +1 more source

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis

Journal of Research in Medical Sciences, 2014
Background: Cytomegalovirus (CMV), a problematic virus in solid organ transplant recipients (SOTR) such as liver, can worsen overall mortality and transplant outcome, so its prevention and treatment is a key of success in such patients.
Siavash Vaziri, Zohre Pezhman, Babak Sayyad, Feizolla Mansouri, Alireza Janbakhsh, Mandana Afsharian, Farid Najafi   +6 more
doaj  

Pre-Transplant Frequencies of FoxP3+CD25+ in CD3+CD8+ T Cells as Potential Predictors for CMV in CMV-Intermediate Risk Kidney Transplant Recipients

Transplant International
Cytomegalovirus (CMV) infection detrimentally influences graft survival in kidney transplant recipients, with the risk primarily determined by recipient and donor serostatus. However, recipient CD8+ T cells play a crucial role in CMV control. The optimal
Agnes A. Mooslechner, Agnes A. Mooslechner, Max Schuller, Verena Pfeifer, Verena Pfeifer, Konstantin A. Klötzer, Barbara Prietl, Barbara Prietl, Alexander H. Kirsch, Philipp Stiegler, Robert Sucher, Harald Sourij, Alexander R. Rosenkranz, Kathrin Eller   +13 more
doaj   +1 more source

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease

Clinical Pharmacology: Advances and Applications, 2009
Heather E Vezina1,2, Richard C Brundage2, Thomas E Nevins3, Henry H Balfour Jr1,31Department of Laboratory Medicine and Pathology, 2Department of Experimental and Clinical Pharmacology, 3Department of Pediatrics, University of ...
Heather E Vezina, Richard C Brundage, Thomas E Nevins, et al   +3 more
doaj  

Hidrops fetal por infección congénita por citomegalovirus: tratamiento posneonatal prolongado con valganciclovir

Revista Chilena de Obstetricia y Ginecología, 2012
El citomegalovirus (CMV) es la infección viral congénita más frecuente con una prevalencia de 0,5% al nacimiento. La primoinfección aparece entre el 1-4% de las gestantes seronegativas.
Silvia Campos Arca, María Fernández Rial, Isabel Pardo Pumar, Cristina Luaces, José García Piñó, Eloy Moral Santamarina   +5 more
doaj  

Association between White Matter T2 Hyper-Intense Signals in Fetal Brain Magnetic Resonance Imaging and Neurodevelopment of Fetuses with Cytomegalovirus Infection

Diagnostics
An association between subtle changes in T2 white matter hyper-intense signals (WMHSs) detected in fetal brain magnetic resonance imaging (fbMRI) and congenital cytomegalovirus (CMV) infection has been established.
Galia Barkai, Eldad Katorza, Simon Lassman, Itachi Levinberg, Chen Hoffmann, Omer Bar-Yosef   +5 more
doaj   +1 more source

Comprehensive insights into cytomegalovirus anterior segment infections: A narrative review

Taiwan Journal of Ophthalmology
Cytomegalovirus (CMV) anterior uveitis (AU), a significant cause of intraocular inflammation, is increasingly recognized in immunocompetent individuals, often leading to visual morbidity if not promptly addressed.
Yih-Shiou Hwang, Po-Yi Wu, Eugene Yu-Chuan Kang, Wei-Chi Wu, Linda Yi-Hsing Chen, Chi-Chun Lai, Kyung Seek Choi   +6 more
doaj   +1 more source

Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis

Clinical Transplantation and Research
Background : Valganciclovir (ValG) is the most widely used drug for cytomegalovirus (CMV) prophylaxis in kidney transplant recipients (KTRs). However, it is associated with dose-limiting side effects and considerable costs.
Leonardo Januário Campos Cardoso, Kleuber Arias Meireles Martins, Paulo Vitor Marques, Ivan Petterson Santana Teixeira, Ester Magalhães, Juan Lima Minkauskas, Isabela Coutinho Faria, Filipe Melo Ribeiro   +7 more
doaj   +1 more source

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

Infection and Drug Resistance, 2019
Guy El Helou,1,2 Raymund R Razonable1,21Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA; 2William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN, USAAbstract ...
El Helou G, Razonable RR
doaj